Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P04156: Variant p.Asp202Asn

Major prion protein
Gene: PRNP
Feedback?
Variant information Variant position: help 202 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Aspartate (D) to Asparagine (N) at position 202 (D202N, p.Asp202Asn). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (D) to medium size and polar (N) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In GSD. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 202 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 253 The length of the canonical sequence.
Location on the sequence: help ITIKQHTVTTTTKGENFTET D VKMMERVVEQMCITQYERES The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         ITIKQHTVTTTTK--------GENFTETDV--KMMERVVEQMCITQYERES

Gorilla                       ITIKQHTVTTTTK--------GENFTETDV--KMMERVVEQ

                              ITVKQHTV-TTTK--------GENFTETDI--KMMERVVEQ

Rhesus macaque                ITIKQHTVTTTTK--------GENFTETDV--KMMERVVEQ

Chimpanzee                    ITIKQHTVTTTTK--------GENFTETDV--KMMERVVEQ

Mouse                         ITIKQHTVTTTTK--------GENFTETDV--KMMERVVEQ

Rat                           ITIKQHTVTTTTK--------GENFTETDV--KMMERVVEQ

Pig                           ITVKQHTVTTTTK--------GENFTETDV--KMIERVVEQ

Bovine                        ITVKEHTVTTTTK--------GENFTETDI--KMMERVVEQ

Rabbit                        ITVKQHTVTTTTK--------GENFTETDI--KIMERVVEQ

Goat                          ITVKQHTVTTTTK--------GENFTETDI--KIMERVVEQ

Sheep                         ITVKQHTVTTTTK--------GENFTETDI--KIMERVVEQ

Cat                           ITVKQHTVTTTTK--------GENFTETDM--KIMERVVEQ

Chicken                       ITVTEYSIGPAAKKNTSEAVAAANQTEVEMENKVVTKVIRE
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 23 – 230 Major prion protein
Region 23 – 230 Interaction with GRB2, ERI3 and SYN1
Glycosylation 197 – 197 N-linked (GlcNAc...) asparagine
Disulfide bond 179 – 214
Beta strand 196 – 202



Literature citations
Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity.
Piccardo P.; Dlouhy S.R.; Lievens P.M.; Young K.; Bird T.D.; Nochlin D.; Dickson D.W.; Vinters H.V.; Zimmerman T.R.; Mackenzie I.R.; Kish S.J.; Ang L.C.; De Carli C.; Pocchiari M.; Brown P.; Gibbs C.J. Jr.; Gajdusek D.C.; Bugiani O.; Ironside J.; Tagliavini F.; Ghetti B.;
J. Neuropathol. Exp. Neurol. 57:979-988(1998)
Cited for: VARIANTS GSD ASN-202 AND PRO-212;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.